Kyle Bauser

Stock Analyst at Roth Capital

(3.75)
# 709
Out of 5,157 analysts
30
Total ratings
48.15%
Success rate
11.6%
Average return

Stocks Rated by Kyle Bauser

LeMaitre Vascular
Feb 26, 2026
Reiterates: Buy
Price Target: $108$117
Current: $109.20
Upside: +7.14%
InfuSystem Holdings
Feb 25, 2026
Reiterates: Buy
Price Target: $14$15
Current: $9.68
Upside: +54.96%
Tactile Systems Technology
Feb 18, 2026
Maintains: Neutral
Price Target: $16$32
Current: $28.11
Upside: +13.84%
Apyx Medical
Dec 16, 2025
Initiates: Buy
Price Target: $6
Current: $3.45
Upside: +73.91%
Microbot Medical
Dec 3, 2025
Initiates: Buy
Price Target: $5.5
Current: $2.52
Upside: +118.25%
Electromed
Nov 13, 2025
Reiterates: Buy
Price Target: $35$36
Current: $23.71
Upside: +51.83%
Stereotaxis
Nov 12, 2025
Reiterates: Buy
Price Target: $4
Current: $1.97
Upside: +103.05%
SANUWAVE Health
Aug 22, 2025
Maintains: Buy
Price Target: $54$55
Current: $22.45
Upside: +144.99%
Varex Imaging
Aug 8, 2025
Maintains: Buy
Price Target: $12$16
Current: $11.23
Upside: +42.48%
Bio-Techne
Jul 9, 2025
Initiates: Buy
Price Target: $65
Current: $52.82
Upside: +23.06%
Initiates: Neutral
Price Target: $15
Current: $12.26
Upside: +22.35%
Initiates: Buy
Price Target: $15
Current: $4.64
Upside: +223.28%
Initiates: Buy
Price Target: n/a
Current: $214.86
Upside: -